Medica presents: COMPASS for Highly Sensitive Rapid Tests
Medica presents: COMPASS for Highly Sensitive Rapid Tests
In collaboration with Erlangen University Hospital, researchers from Julius Maximilian University in Würzburg created a novel tool called COMPASS, which offers far quicker and more accurate testing for determining viral load. The process is quick and equally sensitive as the intricate ELISA tests, requiring very little metrological work.
Read more: Medica presents: COMPASS for Highly Sensitive Rapid Tests
Revolutionary Non-Invasive Diagnostic Techniques
Revolutionary Non-Invasive Diagnostic Techniques
At MEDICA 2023, Testcard will present their cutting-edge non-invasive diagnostic solutions that are intended to increase testing accessibility for both consumers and clinical settings. Their ground-breaking UTI test kit for use at home, which boasts accuracy on par with urine tests carried out in clinical settings. When combined with the mobile application, consumers may get precise test results right away from the comfort of their own homes. TestCard was established in the UK in 2017 with the goal of empowering individuals to take charge of their health by increasing testing accessibility globally. To maintain a full end-to-end trail back to the source for treatment, the system connects directly with each supplier.
Raman Spectroscopic Method Diagnoses Infection at the Point of Care
Raman Spectroscopic Method Diagnoses Infection at the Point of Care
KARINA WEBER AND JÜRGEN POPP, LEIBNIZ INSTITUTE OF PHOTONIC TECHNOLOGY, wrote an article about the Raman Spectroscopic Method Diagnoses Infection at the Point of Care.
Read more: Raman Spectroscopic Method Diagnoses Infection at the Point of Care
Medica two years after the Pandemic: What is new on important Innovation in Medtech, Devices and Biotechnology?
Medica Two Years After The Pandemic: What is New on Important Innovation in Medtech, Devices and Biotechnology?
More than 5,300 exhibitors from over 70 countries coming together on one of the world's most important medical B2B trade shows which is called MEDICA, and it is held in Düsseldorf since decades. This article features the latest news from a broad selection of cutting-edge news, technologies, trends in innovative products and services from the domains of medical imaging, lab technology, diagnostics, health IT, mobile health, physiotherapy/orthopedic technology, and medical supplies.
Rekom Biotech
A biotechnology company called Rekom Biotech is dedicated to creating IVD reagents for in vitro diagnostics. Their used raw materials are of superior quality and adaptable to a wide range of market platforms, including immunochromatography, chemiluminescence, and second and third generation ELISAs. This company is devoted to ensuring the greatest level of quality in the design and manufacture of our IVD reagents, and we conduct rigorous quality control on each batch produced.
The portfolio comprises recombinant proteins for people and animals that are used to diagnose infectious disorders as well as allergies. These proteins can be used for a variety of applications, including raw material for antibody testing, internal controls for antigen assays, and even immunogens to generate antibodies. They are created using a number of different expression techniques to achieve maximal efficacy.
The objective is to improve our proteins' antigenicity, sensitivity, and possible specificity issues. We also provide several of these recombinant proteins in monobiotinylated and HRP-conjugated forms.
Rekom Biotech has specialized in the design and manufacture of next-generation proteins, which are chimeras or proteins made up of numerous epitopes that have better antigenic features such as sensitivity and specificity. Another significant advantage of multi-epitope chimeric proteins is that they eliminate the need for protein mixtures in your test. The restricted number of binding sites and the varying affinities of proteins for these sites may cause reproducibility problems.
There are also polyclonal antibodies, which can be used as raw material for an antigen test or as an internal calibrator for an antibody test; and an inmunoassay blocker for anti-cross-reactive carbohydrate determinants (CCD) antibodies, which will kidnap anti-CCD antibodies and increase the specificity of the assay. Another service they offer is to provide custom-made proteins and antibodies to IVD producers that wish to design a new test but can't locate the proper reagent.